Gala vs Mochi Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Mochi Health beats Gala overall, scoring 7.7/10 vs 7/10. Gala is more affordable at $149/mo vs $178/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Mochi Health for users who want a tech-forward platform with app-based tracki.
A side-by-side comparison of Gala and Mochi Health covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaMochi Health
#18 of 42Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.
Visit Mochi Health| Feature | Gala | Mochi Health |
|---|---|---|
| Our Score | 7/10 | 7.7/10 |
| Starting Price | $149/mo | $178/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want a tech-forward platform with app-based tracking |
| Ranking | #40 | #18 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Mochi Health
Pros
- +Flat $99/mo semaglutide at ALL dose levels — saves $100-200/mo vs competitors who charge more at higher doses
- +4 semaglutide formats: injection, oral tablet, oral drops, and microdose — the most delivery options of any platform
- +Registered dietitians included alongside physicians — not just medication, but nutritional support
- +Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)
Cons
- −Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
- −No refunds for payments made over 30 days ago — limited consumer protection window
- −Relatively new company (founded 2022) with less track record than established platforms
Our Verdict
Mochi Health edges out Gala with a score of 7.7/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Mochi Health's $178/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking.